Untitled

3M Health Care Academy* presents…“Evidence-based Success Story of CRBSI Reduction”

Attendees will learn about a large real-world data study evaluating the impact of incrementally introducing chlorhexidine gluconate (CHG) dressings (sponge or gel) in addition to an ongoing catheter bundle on the rates of CRBSI.

Learning Objectives  |  At the end of this session, participants should be able to:

1. Describe the value of real world evidence over an extended period of time to inform practice improvement
2. Discuss data from a new study in which significant improvement in catheter related infections was achieved despite an increasingly challenging environment
3. Identify essential elements that led to sustained improvement in infection rates

Speaker:

Philippe Eggimann, M.D.  |  Senior Physician  |  Department of Intensive Care Medicine and Burn Center  |  Centre Hospitalier Universitaire Vaudois  |  Lausanne, Switzerland

Continuing Education Information  |  3M is an approved provider by The California Board of Registered Nursing. Provider Number CEP 5770. Each Device Reprocessing 1-hour web meeting is approved by IAHCSMM, CBSPD. These programs provide 1.0 CE contact hour.

Questions should be directed to 3M: 3MHealthCareAcademy@mmm.com

* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.